文献
J-GLOBAL ID:201802231809010922
整理番号:18A0267699
患者由来の孤立性線維性腫瘍異種移植片は臨床で確認されたドキソルビシン/ダカルバジン併用に対する高感度を予測し,この腫瘍に対するトラベクテジンまたはエリブリンの潜在的有効性を強調する【Powered by NICT】
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
著者 (23件):
Stacchiotti S.
(Medical Oncology Unit 2 (Adult Mesenchymal Tumours), Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Saponara M.
(Medical Oncology Unit 2 (Adult Mesenchymal Tumours), Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Frapolli R.
(Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy)
,
Tortoreto M.
(Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Cominetti D.
(Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Provenzano S.
(Medical Oncology Unit 2 (Adult Mesenchymal Tumours), Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Negri T.
(Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Dagrada G.P.
(Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Gronchi A.
(Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Colombo C.
(Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Vincenzi B.
(Department of Oncology, University Campus Bio-Medico, via Alvaro del Portillo 21, Rome, Italy)
,
Badalamenti G.
(Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy)
,
Zuco V.
(Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Renne S.L.
(Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
,
Collini P.
(Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)
,
Morosi C.
(Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Dei Tos A.P.
(Department of Anatomic Pathology, General Hospital of Treviso, Treviso, Italy)
,
Bello E.
(Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy)
,
Pilotti S.
(Laboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Casali P.G.
(Medical Oncology Unit 2 (Adult Mesenchymal Tumours), Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
,
Casali P.G.
(Oncology Department, University of Milan, Italy)
,
D’Incalci M.
(Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy)
,
Zaffaroni N.
(Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
76
ページ:
84-92
発行年:
2017年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)